About GeniPhys
GeniPhys is a company based in Zionsville (United States) founded in 2014.. GeniPhys has raised $10.47 million across 6 funding rounds from investors including National Science Foundation, Pier 70 Ventures and Elevate Ventures. GeniPhys offers products and services including Collymer Technology. GeniPhys operates in a competitive market with competitors including Organogenesis, Sofregen, Collplant, BioTissue and Reapplix, among others.
- Headquarter Zionsville, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Geniphys, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$10.47 M (USD)
in 6 rounds
-
Latest Funding Round
$500 K (USD), Grant
Oct 24, 2024
-
Investors
National Science Foundation
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of GeniPhys
GeniPhys offers a comprehensive portfolio of products and services, including Collymer Technology. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Polymerizable collagen for tissue regeneration and restoration applications.
Unlock access to complete
Unlock access to complete
Leadership Team
3 people
Founder Team
1 people
Chairman Team
1 people
COO Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of GeniPhys
GeniPhys has successfully raised a total of $10.47M across 6 strategic funding rounds. The most recent funding activity was a Grant round of $500 thousand completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Grant — $500,000
-
First Round
First Round
(19 May 2015)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2024 | Amount | Grant - GeniPhys | Valuation |
investors |
|
| Mar, 2023 | Amount | Series A - GeniPhys | Valuation |
investors |
|
| Nov, 2022 | Amount | Series A - GeniPhys | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in GeniPhys
GeniPhys has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include National Science Foundation, Pier 70 Ventures and Elevate Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Early-stage investments are made in diverse sectors by the firm.
|
Founded Year | Domain | Location | |
|
Support for technology commercialization and startup development is provided.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by GeniPhys
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - GeniPhys
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Geniphys Comparisons
Competitors of GeniPhys
GeniPhys operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Organogenesis, Sofregen, Collplant, BioTissue and Reapplix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Regenerative therapies for wound care are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Silk-derived biomaterials are developed for soft tissue repair in surgery.
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
Regenerative biologic therapies for eye care are developed and provided.
|
|
| domain | founded_year | HQ Location |
Developer of patch system for wound healing
|
|
| domain | founded_year | HQ Location |
Developer of regenerative materials
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Geniphys
Frequently Asked Questions about GeniPhys
When was GeniPhys founded?
GeniPhys was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Where is GeniPhys located?
GeniPhys is headquartered in Zionsville, United States. It is registered at Zionsville, Indiana, United States.
Is GeniPhys a funded company?
GeniPhys is a funded company, having raised a total of $10.47M across 6 funding rounds to date. The company's 1st funding round was a Series A of $4.45M, raised on May 19, 2015.
What does GeniPhys do?
GeniPhys was founded in 2014 and is based in Zionsville, United States. Collagen polymers are developed within the biotechnology sector for tissue regeneration. Collymer, a polymerizable collagen-based scaffold, is provided to facilitate tissue restoration. This material is applied in areas such as cartilage replacement, vascular grafts, heart valve replacement, and related medical uses. Operations focus on advancing regenerative medicine solutions.
Who are the top competitors of GeniPhys?
GeniPhys's top competitors include Organogenesis, Collplant and Acera Surgical.
What products or services does GeniPhys offer?
GeniPhys offers Collymer Technology.
Who are GeniPhys's investors?
GeniPhys has 4 investors. Key investors include National Science Foundation, Pier 70 Ventures, Elevate Ventures, and Purdue Innovates.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.